Showing results (271-280 of 359) with videos related to
Sort By:
Pageof 36
Blood|November 5, 2020
Progression signature underlies clonal evolution and dissemination of multiple myelomaYu Jia Shen, Yuji Mishima, Jiantao Shi, et al.Science Signaling|June 9, 2021
Metabolic perturbations sensitize triple-negative breast cancers to apoptosis induced by BH3 mimeticsVeerle W Daniels, Jason J Zoeller, Nick van Gastel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 12, 2022
Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell NeoplasmNaveen Pemmaraju, Kendra L Sweet, Anthony S Stein, et al.Nature Genetics|November 22, 2016
Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex biasAndrew Dunford, David M Weinstock, Virginia Savova, et al.Haematologica|January 15, 2026
First-line tagraxofusp leads to durable responses and prolonged survival in adults with blastic plasmacytoid dendritic cell neoplasm regardless of fitness levelNaveen Pemmaraju, Marco Herling, Kendra L Sweet, et al.Blood|February 6, 2025
PSTK inhibition activates cGAS-STING, precipitating ferroptotic cell death in leukemic stem cellsLingli He, Ting Zhao, Wei Zhong Leong, et al.Proceedings of the National Academy of Sciences of the United States of America|March 3, 2010
Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone diseaseSonia Vallet, Siddhartha Mukherjee, Nileshwari Vaghela, et al.Biorxiv : the Preprint Server for Biology|September 5, 2025
Human progenitor T-cell differentiation regulated by the mechanical resistance of thymus-mimetic extracellular matricesNicholas Jeffreys, Kyle T Ruark, Joshua M Price, et al.Nature Communications|February 7, 2023
Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analysesTaghreed Hirz, Shenglin Mei, Hirak Sarkar, et al.Haematologica|July 13, 2023
Down syndrome and leukemia: from basic mechanisms to clinical advancesAndré Baruchel, Jean-Pierre Bourquin, John Crispino, et al.Pageof 36